These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 21858043)

  • 1. The kinase inhibitor SFV785 dislocates dengue virus envelope protein from the replication complex and blocks virus assembly.
    Anwar A; Hosoya T; Leong KM; Onogi H; Okuno Y; Hiramatsu T; Koyama H; Suzuki M; Hagiwara M; Garcia-Blanco MA
    PLoS One; 2011; 6(8):e23246. PubMed ID: 21858043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Y-Box Binding Protein 1 Interacts with Dengue Virus Nucleocapsid and Mediates Viral Assembly.
    Diosa-Toro M; Kennedy DR; Chuo V; Popov VL; Pompon J; Garcia-Blanco MA
    mBio; 2022 Feb; 13(1):e0019622. PubMed ID: 35189699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of Acidic Intracellular Vesicles by Niclosamide Inhibits Multiple Steps of the Dengue Virus Life Cycle In Vitro.
    Jung E; Nam S; Oh H; Jun S; Ro HJ; Kim B; Kim M; Go YY
    Sci Rep; 2019 Jun; 9(1):8682. PubMed ID: 31213630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the mode of action of a potent dengue virus capsid inhibitor.
    Scaturro P; Trist IM; Paul D; Kumar A; Acosta EG; Byrd CM; Jordan R; Brancale A; Bartenschlager R
    J Virol; 2014 Oct; 88(19):11540-55. PubMed ID: 25056895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
    Hernandez-Morales I; Geluykens P; Clynhens M; Strijbos R; Goethals O; Megens S; Verheyen N; Last S; McGowan D; Coesemans E; De Boeck B; Stoops B; Devogelaere B; Pauwels F; Vandyck K; Berke JM; Raboisson P; Simmen K; Lory P; Van Loock M
    Antiviral Res; 2017 Nov; 147():149-158. PubMed ID: 29037976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus.
    Soto-Acosta R; Bautista-Carbajal P; Syed GH; Siddiqui A; Del Angel RM
    Antiviral Res; 2014 Sep; 109():132-40. PubMed ID: 25017471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and structure-activity relationship analysis of a class of antiviral compounds that directly bind dengue virus capsid protein and are incorporated into virions.
    Smith JL; Sheridan K; Parkins CJ; Frueh L; Jemison AL; Strode K; Dow G; Nilsen A; Hirsch AJ
    Antiviral Res; 2018 Jul; 155():12-19. PubMed ID: 29709563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cordycepin Inhibits Virus Replication in Dengue Virus-Infected Vero Cells.
    Panya A; Songprakhon P; Panwong S; Jantakee K; Kaewkod T; Tragoolpua Y; Sawasdee N; Lee VS; Nimmanpipug P; Yenchitsomanus PT
    Molecules; 2021 May; 26(11):. PubMed ID: 34071102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleoside Analogs with Selective Antiviral Activity against Dengue Fever and Japanese Encephalitis Viruses.
    Zandi K; Bassit L; Amblard F; Cox BD; Hassandarvish P; Moghaddam E; Yueh A; Libanio Rodrigues GO; Passos I; Costa VV; AbuBakar S; Zhou L; Kohler J; Teixeira MM; Schinazi RF
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.
    Panya A; Sawasdee N; Junking M; Srisawat C; Choowongkomon K; Yenchitsomanus PT
    Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry.
    Kuo YT; Liu CH; Li JW; Lin CJ; Jassey A; Wu HN; Perng GC; Yen MH; Lin LT
    Sci Rep; 2020 Oct; 10(1):16378. PubMed ID: 33009425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of dengue virus by an ester prodrug of an adenosine analog.
    Chen YL; Yin Z; Lakshminarayana SB; Qing M; Schul W; Duraiswamy J; Kondreddi RR; Goh A; Xu HY; Yip A; Liu B; Weaver M; Dartois V; Keller TH; Shi PY
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3255-61. PubMed ID: 20516277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of geraniin on dengue virus type-2 infected BALB/c mice.
    Abdul Ahmad SA; Palanisamy UD; Khoo JJ; Dhanoa A; Syed Hassan S
    Virol J; 2019 Feb; 16(1):26. PubMed ID: 30813954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.
    Beesetti H; Tyagi P; Medapi B; Krishna VS; Sriram D; Khanna N; Swaminathan S
    Antivir Ther; 2018; 23(5):385-394. PubMed ID: 29583121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of dengue virus envelope protein with endoplasmic reticulum-resident chaperones facilitates dengue virus production.
    Limjindaporn T; Wongwiwat W; Noisakran S; Srisawat C; Netsawang J; Puttikhunt C; Kasinrerk W; Avirutnan P; Thiemmeca S; Sriburi R; Sittisombut N; Malasit P; Yenchitsomanus PT
    Biochem Biophys Res Commun; 2009 Feb; 379(2):196-200. PubMed ID: 19105951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dengue Virus Selectively Annexes Endoplasmic Reticulum-Associated Translation Machinery as a Strategy for Co-opting Host Cell Protein Synthesis.
    Reid DW; Campos RK; Child JR; Zheng T; Chan KWK; Bradrick SS; Vasudevan SG; Garcia-Blanco MA; Nicchitta CV
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro effect of human cathelicidin antimicrobial peptide LL-37 on dengue virus type 2.
    Alagarasu K; Patil PS; Shil P; Seervi M; Kakade MB; Tillu H; Salunke A
    Peptides; 2017 Jun; 92():23-30. PubMed ID: 28400226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An estrogen antagonist, cyclofenil, has anti-dengue-virus activity.
    Tohma D; Tajima S; Kato F; Sato H; Kakisaka M; Hishiki T; Kataoka M; Takeyama H; Lim CK; Aida Y; Saijo M
    Arch Virol; 2019 Jan; 164(1):225-234. PubMed ID: 30357482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel dengue virus inhibitor 4-HPR activates ATF4 independent of protein kinase R-like Endoplasmic Reticulum Kinase and elevates levels of eIF2α phosphorylation in virus infected cells.
    Fraser JE; Wang C; Chan KW; Vasudevan SG; Jans DA
    Antiviral Res; 2016 Jun; 130():1-6. PubMed ID: 26965420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteolin restricts dengue virus replication through inhibition of the proprotein convertase furin.
    Peng M; Watanabe S; Chan KWK; He Q; Zhao Y; Zhang Z; Lai X; Luo D; Vasudevan SG; Li G
    Antiviral Res; 2017 Jul; 143():176-185. PubMed ID: 28389141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.